Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynette M Phee

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Antimicrobial Chemotherapy|March 27, 2018
Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devicesDavid W Wareham, Lynette M Phee, Muhd Haziq F Abdul Momin
The Ocular Surface|November 12, 2021
Atypical microbial keratitisHon Shing Ong, Namrata Sharma, Lynette M Phee, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii InfectionsLynette M Phee, Jonathan W Betts, Binutha Bharathan, et al.
Journal of Natural Products|August 13, 2015
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureusJonathan W Betts, Amir S Sharili, Lynette M Phee, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant EnterobacteriaceaeJonathan W Betts, Lynette M Phee, Michael Hornsey, et al.
Journal of Global Antimicrobial Resistance|May 2, 2017
Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei DarussalamMuhd Haziq Fikry Abdul Momin, Apostolos Liakopoulos, Lynette M Phee, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 6, 2016
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak CloneOlga Oikonomou, Apostolos Liakopoulos, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2019
Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumanniiLynette M Phee, Frank Kloprogge, Rebecca Morris, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' responseDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Antimicrobial Chemotherapy|March 27, 2018
Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devicesDavid W Wareham, Lynette M Phee, Muhd Haziq F Abdul Momin
The Ocular Surface|November 12, 2021
Atypical microbial keratitisHon Shing Ong, Namrata Sharma, Lynette M Phee, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii InfectionsLynette M Phee, Jonathan W Betts, Binutha Bharathan, et al.
Journal of Natural Products|August 13, 2015
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureusJonathan W Betts, Amir S Sharili, Lynette M Phee, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant EnterobacteriaceaeJonathan W Betts, Lynette M Phee, Michael Hornsey, et al.
Journal of Global Antimicrobial Resistance|May 2, 2017
Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei DarussalamMuhd Haziq Fikry Abdul Momin, Apostolos Liakopoulos, Lynette M Phee, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 6, 2016
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak CloneOlga Oikonomou, Apostolos Liakopoulos, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|January 10, 2019
Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumanniiLynette M Phee, Frank Kloprogge, Rebecca Morris, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infectionsDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2020
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' responseDavid W Wareham, M H F Abdul Momin, Lynette M Phee, et al.
Pageof 2